Trinity Biotech (TRIB) Short-Term Debt repayments (2021 - 2024)
Trinity Biotech recorded quarterly Short-Term Debt repayments of -$665000.0 in Q4 2024, down 19.18% quarter-over-quarter from -$558000.0 in Q4 2023, and down 19.18% year-over-year from -$822771.6 in Q1 2024.
Trinity Biotech's Short-Term Debt repayments history runs 4 years deep, the most recent figure standing at -$665000.0 for Q4 2024.
- In Q4 2024, Short-Term Debt repayments fell 19.18% year-over-year to -$665000.0; the TTM figure through Dec 2024 stood at -$2.4 million (up 0.79% YoY), while the FY2024 annual figure was -$2.5 million, up 75.09% from the prior year.
- Short-Term Debt repayments came in at -$665000.0 for Q4 2024 at Trinity Biotech, down from -$558000.0 in the prior quarter.
- In the past five years, Short-Term Debt repayments ranged from a high of -$743.0 in Q2 2021 to a low of -$741000.0 in Q4 2021.
- A 4-year average of -$478905.4 and a median of -$574000.0 in 2022 frame the typical range for Short-Term Debt repayments.
- On a YoY basis, Short-Term Debt repayments climbed as much as 22.13% in 2022 and fell as far as 4543.34% in 2022.
- Trinity Biotech's Short-Term Debt repayments stood at -$741000.0 in 2021, then advanced by 22.13% to -$577000.0 in 2022, then rose by 3.29% to -$558000.0 in 2023, then retreated by 19.18% to -$665000.0 in 2024.
- According to Business Quant data, Short-Term Debt repayments over the past three periods registered -$665000.0, -$558000.0, and -$571000.0 for Q4 2024, Q4 2023, and Q3 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 259.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -665,000.00 |
| Dec 31, 2024 | -665,000.00 |
| Dec 31, 2023 | -558,000.00 |
| Dec 31, 2023 | -558,000.00 |
| Sep 30, 2023 | -571,000.00 |
| Sep 30, 2023 | -571,000.00 |
| Dec 31, 2022 | -577,000.00 |
| Dec 31, 2022 | -577,000.00 |
| Sep 30, 2022 | -684,000.00 |
| Sep 30, 2022 | -684,000.00 |
| Jun 30, 2022 | -34,500.00 |
| Jun 30, 2022 | -34,500.00 |
| Dec 31, 2021 | -741,000.00 |
| Dec 31, 2021 | -741,000.00 |
| Jun 30, 2021 | -743.00 |
| Jun 30, 2021 | -743.00 |